Latest Financial Turnaround News

Morphic Ethical Equities Fund Limited reported a strong turnaround in FY2025 with a $5.44 million net profit and portfolio returns surpassing its benchmark, while continuing aggressive share buybacks despite withholding dividends.

RLF AgTech Ltd has secured $4.5 million through a discounted share placement to support its strategic growth initiatives following a robust 74% revenue increase in FY2025. The company is advancing its Australian relaunch, expanding manufacturing, and entering new Asian markets.

Resolute Mining Limited reported a robust half-year performance for H1 2025, with net profit more than doubling amid higher gold prices, even as production dipped due to operational challenges. The company also expanded its footprint with a strategic acquisition in Côte d’Ivoire.

Guzman y Gomez Limited (GYG) reported a strong FY25 turnaround with revenue up 27% and a maiden fully franked dividend declared, underpinned by robust Australia segment growth and ongoing US expansion.

Credit Clear Limited has reported a remarkable turnaround in FY25, posting record revenue growth and a return to profitability driven by its innovative AI-powered debt resolution platform.

AMA Group Limited reported a robust FY25 with revenue climbing 8.6% to over $1 billion and a 38.4% jump in normalised EBITDA, while significantly reducing net debt following a major equity raise and debt refinancing.

Regis Resources has posted a record net profit of $254 million for FY25, driven by strong gold prices and operational efficiency, while declaring a fully franked 5 cent dividend per share. The company sets a confident tone for FY26 with steady production guidance and disciplined capital allocation.

Regis Resources Limited delivered a strong FY25 with record revenue and net profit, becoming debt-free and declaring a dividend, while advancing its underground growth strategy. However, its McPhillamys Gold Project faces a significant legal hurdle following a heritage protection declaration.

Australian Vintage Ltd reported a modest 1% revenue decline in FY25 but significantly narrowed its net loss, setting the stage for a transformational FY26 driven by new CEO leadership and innovative product launches.

Medical Developments International has reported a remarkable turnaround in FY25, posting a net profit after tax and securing paediatric approval for its flagship product Penthrox in Europe.

Medical Developments International Ltd reported an 18% increase in revenue to $39.1 million for FY25, returning to profitability with a net profit after tax of $0.1 million. The company advanced its Penthrox market expansion through regulatory approvals and new partnerships.

Medical Developments International reports a strong FY25 with significant margin gains and strategic progress, setting the stage for accelerated Penthrox expansion in FY26.